Incyte Corp. sell BMO Capital Markets
Start price
30.10.24
/
50%
€67.26
Target price
30.10.25
€47.90
Performance (%)
18.53%
End price
31.10.25
€79.72
Summary
This prediction ended on 31.10.25 with a price of €79.72. The prediction closed with a disappointing performance of 18.53%. BMO_Capital_Markets has a follow-up prediction for Incyte Corp. where he still thinks Incyte Corp. is a Sell. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Incyte Corp. | 2.237% | 2.237% | 25.726% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by BMO_Capital_Markets for this prediction
In the thread Incyte Corp. diskutieren
Incyte Co. (NASDAQ: INCY) had its "underperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $52.00 price target on the stock, up previously from $48.00.
Ratings data for INCY provided by MarketBeat
In the thread Trading Incyte Corp.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten